A Legacy of Excellence and Innovation
Founded in 1998 and headquartered in the vibrant industrial hub of Taizhou, Zhejiang, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (Jiuzhou Pharma) has steadily evolved from a generic Active Pharmaceutical Ingredient (API) manufacturer to a beacon of innovation in the contract development and manufacturing organization (CDMO) sector. Our journey has been marked by a relentless commitment to excellence and innovation, catering to the dynamic needs of global pharmaceutical companies.
Leading the Way in Green Pharmaceutical Manufacturing
At Jiuzhou Pharma, we are not only experts in drug development but also pioneers in environmentally friendly pharmaceutical technologies. With proprietary technologies and a focus on sustainable production, we have established ourselves as leaders in green manufacturing, ensuring that every product we develop not only meets but exceeds the stringent requirements of safety, quality, and environmental stewardship.
Our Commitment: Serve Life, Guard Health
Our mission is straightforward yet profound: “Serve life, guard health.” As a distinguished global life science company, we are dedicated to providing cutting-edge drug solutions that accelerate the market delivery of innovative drugs, ultimately benefiting patients worldwide. Our approach is holistic, supporting our partners from preclinical stages through to commercialization with a comprehensive suite of services across Drug Substance (DS) and Drug Product (DP) development.
A Global Footprint with a Local Touch
With over 900 clients worldwide, including a significant presence in Western pharmaceutical and biotech industries, Jiuzhou Pharma has a robust global footprint. Our business model, which focuses on Full-Time Equivalent (FTE) and Fee-For-Service (FFS) engagements, along with a track record of 1,000+ delivered projects, illustrates our capability and commitment to our clients’ success.
Intellectual Property and Trade Secret Protection
In an industry where intellectual property is crucial, Jiuzhou Pharma has implemented robust data leakage prevention systems and access controls. We have successfully passed intellectual property audits by major clients in the United States and Europe, reinforcing our commitment to protecting the innovations that drive the pharmaceutical industry forward.
Unmatched Technical Excellence and Innovative Platforms
Our technical platforms are at the heart of our operational excellence. With more than 800 experienced scientists, over half of whom hold PhD and MSc degrees, we are at the forefront of pharmaceutical development. Our capabilities range from chiral ligands for asymmetric transformations and fluorination to peptides, conjugates, and advanced formulation R&D and production. Our facilities boast state-of-the-art CGMP labs in both China and the USA, equipped to handle processes ranging from small-scale batches to commercial quantities.
Advanced Chiral and Asymmetric Synthesis Technologies
Jiuzhou Pharma is at the forefront of chiral technology, specializing in asymmetric transformations which are crucial for developing new, more effective pharmaceutical agents with fewer side effects. Our proprietary chiral ligands and catalysts allow for high selectivity and yield in these transformations, critical for the scalable production of chiral drugs.
State-of-the-Art Fluorination Chemistry
Fluorination is a pivotal transformation in pharmaceutical synthesis, often enhancing the biological activity and stability of therapeutic compounds. Our leading technology platform for fluorination chemistry is equipped with specialized reactors and processes that allow for precise and scalable fluorination. This capability ensures that we can meet the growing demand for fluorinated pharmaceuticals, which are increasingly prevalent in the development of new medications.
Revolutionary Flow Chemistry Technology
Flow chemistry is another cornerstone of our technological prowess. This technique offers numerous advantages over traditional batch chemistry, including enhanced safety, scalability, and sustainability. Our flow chemistry laboratories are equipped with cutting-edge systems, such as the Corning flow reactor and British C-Tech Innovation electrochemical reactors. These facilities are designed to perform a wide array of reactions, including diazotization, Grignard, nitration/nitrosation, and more, under controlled conditions that maximize yield and minimize waste.
Peptide and Conjugate Drug Development
Our expertise extends into the specialized field of peptides and conjugate drugs, where precision and efficacy are paramount. We provide comprehensive services from preclinical development to commercialization, supporting our clients through every phase of development. Our technologies facilitate the synthesis of highly complex peptides and drug conjugates, enabling the creation of next-generation therapies for a range of diseases.
Comprehensive Solid-State Chemistry and Separation Sciences
Solid-state chemistry and separation sciences are critical for the optimization of pharmaceutical products. Our technologies in this area include advanced techniques for crystal form screening, polymorph identification, and the purification of final products. This ensures that our APIs have optimal bioavailability, stability, and efficacy.
Excellence in Health, Safety, Quality, and Environment (HSEQ)
Jiuzhou Pharma consistently ranks as the number one Environmental, Health, and Safety (EHS) performer in our local industrial park. Our adherence to global regulatory standards is not just a compliance measure but a testament to our commitment to quality and safety. We have successfully passed multiple inspections and audits from worldwide regulatory authorities and multinational pharmaceutical companies, affirming our dedication to maintaining the highest standards of quality and safety.
Looking to the Future
As we look forward, Jiuzhou Pharma remains committed to expanding its technological boundaries and enhancing its service offerings to meet and anticipate the needs of our partners and the broader pharmaceutical industry. Our goal is not just to be a part of the industry but to set the benchmarks for quality, innovation, and sustainability in pharmaceutical development.
